| Typicality: | 0.385 |
| Saliency: | 0.315 |
| at two doses | 2 | temporal |
| in the first study | 2 | location |
| colleague → evaluate → tolerability | 5 |
| colleague → compare → tolerability | 4 |
| colleague → examine → tolerability | 3 |
| negative | neutral | positive |
| 0.049 | 0.788 | 0.162 |
| Raw frequency | 12 |
| Normalized frequency | 0.315 |
| Modifier score | 0.500 |
| Perplexity | 285.688 |